GENE ONLINE|News &
Opinion
Blog

SK Biopharmaceuticals
Deals SK Biopharmaceuticals
SK Biopharma Teams Up with Targeted Protein Degrader Ubix
2022-04-15
Asia-Pacific CDMO
South Korea’s SK Inc., Develops Its CDMO Capabilities via Investment in the Center for Breakthrough Medicines
2022-01-21
Asia-Pacific SK Life Science
SK Life Science Steps Forward in Treating Seizure Disorders
2022-01-13
Asia-Pacific Neuroscience
SK Biopharm Spinout Launches with $180 Million to Bring Neuroscience Drugs to China
2021-11-12
M&A Anti-seizure
Angelini Aims for CNS Dominance with Arvelle Therapeutics Acquisition
2021-01-10
Anti-epileptic Drug
South Korean Biotech Finds Strategic Partner to Advance Epileptic Treatment Options
2020-10-15
Asia-Pacific Tepotinib
Weekly in Asia｜Nov-2
2019-11-27
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top